Diagnostic Utility of SGLT2 Inhibitors to Facilitate Myocardial Glucose Suppression During Evaluation of Myocardial Inflammation.
作者信息
Selvaraj Senthil, Vidula Mahesh K, Claggett Brian, Rojulpote Chaitanya, Bhattaru Abhijit, Clancy Caitlin B, Rossman Milton, Pryma Daniel A, Goldberg Lee R, Bravo Paco E
出版信息
JACC Cardiovasc Imaging. 2024 Jul;17(7):827-829. doi: 10.1016/j.jcmg.2024.02.011. Epub 2024 Apr 3.
Abstract
摘要
相似文献
1
Diagnostic Utility of SGLT2 Inhibitors to Facilitate Myocardial Glucose Suppression During Evaluation of Myocardial Inflammation.在心肌炎症评估期间，SGLT2抑制剂促进心肌葡萄糖抑制的诊断效用。
JACC Cardiovasc Imaging. 2024 Jul;17(7):827-829. doi: 10.1016/j.jcmg.2024.02.011. Epub 2024 Apr 3.
2
Effect of Sodium-Glucose Cotransport-2 Inhibitors on Blood Pressure in People With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 43 Randomized Control Trials With 22 528 Patients.钠-葡萄糖协同转运蛋白2抑制剂对2型糖尿病患者血压的影响：对43项随机对照试验（涉及22528例患者）的系统评价和荟萃分析
J Am Heart Assoc. 2017 May 25;6(6):e004007. doi: 10.1161/JAHA.116.004007.
3
The impact of metformin on kidney disease progression and mortality in diabetic patients using SGLT2 inhibitors: a real-world cohort study.二甲双胍对使用钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂的糖尿病患者肾脏疾病进展和死亡率的影响：一项真实世界队列研究。
Cardiovasc Diabetol. 2025 Feb 28;24(1):97. doi: 10.1186/s12933-025-02643-6.
4
A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function, and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.一项前瞻性随机研究：比较恩格列净与西格列汀对早期2型糖尿病患者心脏脂肪堆积、心脏功能和心脏代谢的影响——资产研究。
Cardiovasc Diabetol. 2021 Feb 2;20(1):32. doi: 10.1186/s12933-021-01228-3.
5
How should we monitor the cardiovascular benefit of sodium-glucose cotransporter 2 inhibition?我们应如何监测钠-葡萄糖协同转运蛋白2抑制剂的心血管获益？
Cardiovasc Diabetol. 2020 Dec 7;19(1):206. doi: 10.1186/s12933-020-01191-5.
6
Fanconi syndrome associated with SGLT2 inhibitor, canagliflozin.与钠-葡萄糖协同转运蛋白2抑制剂卡格列净相关的范科尼综合征。
Nephrology (Carlton). 2018 May;23(5):493. doi: 10.1111/nep.13094.
7
Impact of sodium-glucose transport protein-2 (SGLT2) inhibitors on the inflammasome pathway in acute myocardial infarction in type 2 diabetes mellitus: a comprehensive review.钠-葡萄糖协同转运蛋白2（SGLT2）抑制剂对2型糖尿病急性心肌梗死炎症小体通路的影响：一项综述
Cardiovasc Diabetol. 2025 May 26;24(1):227. doi: 10.1186/s12933-025-02777-7.
8
Sodium Glucose Cotransporter 2 Inhibition Heralds a Call-to-Action for Diabetic Kidney Disease.钠-葡萄糖协同转运蛋白2抑制剂预示着糖尿病肾病防治行动的号角。
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):285-288. doi: 10.2215/CJN.07730719. Epub 2019 Nov 18.
9
Favorable pleiotropic effects of sodium glucose cotransporter 2 inhibitors: head-to-head comparisons with dipeptidyl peptidase-4 inhibitors in type 2 diabetes patients.钠-葡萄糖共转运蛋白 2 抑制剂的有利的多效性作用：与 2 型糖尿病患者的二肽基肽酶-4 抑制剂的头对头比较。
Cardiovasc Diabetol. 2020 Feb 12;19(1):17. doi: 10.1186/s12933-020-0990-2.
10
Switching Dipeptidyl Peptidase-4 Inhibitors to Tofogliflozin, a Selective Inhibitor of Sodium-Glucose Cotransporter 2 Improve Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Type 2 Diabetes: A Pilot Study.将二肽基肽酶-4 抑制剂转换为钠-葡萄糖共转运蛋白 2 选择性抑制剂托格列净可改善 2 型糖尿病患者的动脉僵硬度：一项初步研究。
Curr Vasc Pharmacol. 2019;17(4):411-420. doi: 10.2174/1570161116666180515154555.
引用本文的文献
1
SGLT2 Inhibitor Treatment Is Associated With Reduced Cardiac Glucose Metabolism: A Matched FDG-PET Cohort Study.钠-葡萄糖协同转运蛋白2抑制剂治疗与心脏葡萄糖代谢降低相关：一项匹配的氟代脱氧葡萄糖正电子发射断层扫描队列研究。
JACC Adv. 2025 Jul 24;4(8):102016. doi: 10.1016/j.jacadv.2025.102016.
2
Metabolic Effects of the SGLT2 Inhibitor Dapagliflozin in Heart Failure Across the Spectrum of Ejection Fraction.钠-葡萄糖协同转运蛋白 2 抑制剂达格列净对射血分数不同心衰患者的代谢影响
Circ Heart Fail. 2024 Nov;17(11):e011980. doi: 10.1161/CIRCHEARTFAILURE.124.011980. Epub 2024 Oct 18.
3
How to prepare a patient for 18F-fluorodeoxyglucose positron emission tomography imaging to assess myocardial inflammation.如何为患者进行18F-氟脱氧葡萄糖正电子发射断层显像以评估心肌炎症做准备。
J Nucl Cardiol. 2024 Aug;38:101888. doi: 10.1016/j.nuclcard.2024.101888. Epub 2024 Jun 1.
本文引用的文献
1
Metabolomic Signatures of Myocardial Glucose Uptake on Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography.18F-氟脱氧葡萄糖正电子发射断层显像中心肌葡萄糖摄取的代谢组学特征
JACC Basic Transl Sci. 2022 Oct 31;7(12):1264-1266. doi: 10.1016/j.jacbts.2022.09.011. eCollection 2022 Dec.
2
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HF.达格列净对射血分数降低的心力衰竭影响的代谢组学分析：DEFINE-HF 研究。
Circulation. 2022 Sep 13;146(11):808-818. doi: 10.1161/CIRCULATIONAHA.122.060402. Epub 2022 May 23.
3
Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial.外源性酮体给药与饮食碳水化合物限制对心肌葡萄糖抑制的比较：一项交叉临床试验。
J Nucl Med. 2022 May;63(5):770-776. doi: 10.2967/jnumed.121.262734. Epub 2021 Oct 21.
4
SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial.SGLT2 抑制剂不会影响心肌脂肪酸氧化或摄取，但会降低 2 型糖尿病患者的心肌葡萄糖摄取和血流：一项随机、双盲、安慰剂对照交叉试验。
Diabetes. 2021 Mar;70(3):800-808. doi: 10.2337/db20-0921. Epub 2020 Dec 17.
5
Patient preparation for cardiac fluorine-18 fluorodeoxyglucose positron emission tomography imaging of inflammation.用于炎症的心脏氟-18氟脱氧葡萄糖正电子发射断层显像的患者准备
J Nucl Cardiol. 2017 Feb;24(1):86-99. doi: 10.1007/s12350-016-0502-7. Epub 2016 Jun 8.
Zotero 插件